A detailed history of Pictet Asset Management Holding Sa transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 3,327,214 shares of TGTX stock, worth $59.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,327,214
Previous 3,385,245 1.71%
Holding current value
$59.2 Million
Previous $57.8 Million 12.48%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.02 - $21.3 $755,563 - $1.24 Million
-58,031 Reduced 1.71%
3,327,214 $50.6 Million
Q4 2023

Feb 13, 2024

BUY
$6.68 - $18.81 $17.1 Million - $48.2 Million
2,564,842 Added 312.63%
3,385,245 $57.8 Million
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $6.86 Million - $21.7 Million
820,403 New
820,403 $6.86 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $2.58B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.